Pesquisa | BVS Odontologia

1.

Effectiveness of telaprevir or boceprevir in treatment-experienced patients with HCV genotype 1 infection and cirrhosis.

Hézode, Christophe; Fontaine, Helene; Dorival, Celine; Zoulim, Fabien; Larrey, Dominique; Canva, Valerie; De Ledinghen, Victor; Poynard, Thierry; Samuel, Didier; Bourliere, Marc; Alric, Laurent; Raabe, Jean-Jacques; Zarski, Jean-Pierre; Marcellin, Patrick; Riachi, Ghassan; Bernard, Pierre-Henri; Loustaud-Ratti, Veronique; Chazouilleres, Olivier; Abergel, Armand; Guyader, Dominique; Metivier, Sophie; Tran, Albert; Di Martino, Vincent; Causse, Xavier; Dao, Thong; Lucidarme, Damien; Portal, Isabelle; Cacoub, Patrice; Gournay, Jerome; Grando-Lemaire, Veronique; Hillon, Patrick; Attali, Pierre; Fontanges, Thierry; Rosa, Isabelle; Petrov-Sanchez, Ventzislava; Barthe, Yoann; Pawlotsky, Jean-Michel; Pol, Stanislas; Carrat, Fabrice; Bronowicki, Jean-Pierre.

Gastroenterology ; 147(1): 132-142.e4, 2014 Jul.

Artigo em Inglês | MEDLINE | ID: mdl-24704719

2.

Improved inflammatory activity with peginterferon alfa-2b maintenance therapy in non-cirrhotic prior non-responders: a randomized study.

Poynard, Thierry; Bruix, Jordi; Schiff, Eugene R; Diago, Moises; Berg, Thomas; Moreno-Otero, Ricardo; Lyra, Andre C; Carrilho, Flair; Griffel, Louis H; Boparai, Navdeep; Jiang, Ruiyun; Burroughs, Margaret; Brass, Clifford A; Albrecht, Janice K.

J Hepatol ; 58(3): 452-9, 2013 Mar.

Artigo em Inglês | MEDLINE | ID: mdl-23159770

3.

Factors that predict response of patients with hepatitis C virus infection to boceprevir.

Poordad, Fred; Bronowicki, Jean-Pierre; Gordon, Stuart C; Zeuzem, Stefan; Jacobson, Ira M; Sulkowski, Mark S; Poynard, Thierry; Morgan, Timothy R; Molony, Cliona; Pedicone, Lisa D; Sings, Heather L; Burroughs, Margaret H; Sniukiene, Vilma; Boparai, Navdeep; Goteti, Venkata S; Brass, Clifford A; Albrecht, Janice K; Bacon, Bruce R.

Gastroenterology ; 143(3): 608-618.e5, 2012 Sep.

Artigo em Inglês | MEDLINE | ID: mdl-22626609

4.

Interferon-gamma with peginterferon alpha-2a and ribavirin in nonresponder patients with chronic hepatitis C (ANRS HC16 GAMMATRI).

Couzigou, Patrice; Pérusat, Sophie; Bourlière, Marc; Trimoulet, Pascale; Poynard, Thierry; Leroy, Vincent; Marcellin, Patrick; Foucher, Juliette; Bronowicki, Jean-Pierre; Chêne, Geneviève.

J Gastroenterol Hepatol ; 28(2): 329-34, 2013 Feb.

Artigo em Inglês | MEDLINE | ID: mdl-23190183

5.

Maintenance therapy with peginterferon alfa-2b does not prevent hepatocellular carcinoma in cirrhotic patients with chronic hepatitis C.

Bruix, Jordi; Poynard, Thierry; Colombo, Massimo; Schiff, Eugene; Burak, Kelly; Heathcote, Elizabeth J L; Berg, Thomas; Poo, Jorge-Luis; Mello, Carlos Brandao; Guenther, Rainer; Niederau, Claus; Terg, Ruben; Bedossa, Pierre; Boparai, Navdeep; Griffel, Louis H; Burroughs, Margaret; Brass, Clifford A; Albrecht, Janice K.

Gastroenterology ; 140(7): 1990-9, 2011 Jun.

Artigo em Inglês | MEDLINE | ID: mdl-21419770

6.

FibroTest is an independent predictor of virologic response in chronic hepatitis C patients retreated with pegylated interferon alfa-2b and ribavirin in the EPIC³ program.

Poynard, Thierry; Munteanu, Mona; Colombo, Massimo; Bruix, Jordi; Schiff, Eugene; Terg, Ruben; Flamm, Steven; Moreno-Otero, Ricardo; Carrilho, Flair; Schmidt, Warren; Berg, Thomas; McGarrity, Thomas; Heathcote, E Jenny; Gonçales, Fernando; Diago, Moises; Craxi, Antonio; Silva, Marcelo; Boparai, Navdeep; Griffel, Louis; Burroughs, Margaret; Brass, Clifford; Albrecht, Janice.

J Hepatol ; 54(2): 227-35, 2011 Feb.

Artigo em Inglês | MEDLINE | ID: mdl-21056496

7.

Assessment of adrenal function in cirrhotic patients: salivary cortisol should be preferred.

Galbois, Arnaud; Rudler, Marika; Massard, Julien; Fulla, Yvonne; Bennani, Abdelhai; Bonnefont-Rousselot, Dominique; Thibault, Vincent; Reignier, Stéphanie; Bourrier, Anne; Poynard, Thierry; Thabut, Dominique.

J Hepatol ; 52(6): 839-45, 2010 Jun.

Artigo em Inglês | MEDLINE | ID: mdl-20385427

8.

Peginterferon alfa-2b and ribavirin: effective in patients with hepatitis C who failed interferon alfa/ribavirin therapy.

Poynard, Thierry; Colombo, Massimo; Bruix, Jordi; Schiff, Eugene; Terg, Ruben; Flamm, Steven; Moreno-Otero, Ricardo; Carrilho, Flair; Schmidt, Warren; Berg, Thomas; McGarrity, Thomas; Heathcote, E Jenny; Gonçales, Fernando; Diago, Moises; Craxi, Antonio; Silva, Marcelo; Bedossa, Pierre; Mukhopadhyay, Pabak; Griffel, Louis; Burroughs, Margaret; Brass, Clifford; Albrecht, Janice.

Gastroenterology ; 136(5): 1618-28.e2, 2009 May.

Artigo em Inglês | MEDLINE | ID: mdl-19208349

9.

Efficacy and safety of adefovir dipivoxil plus pegylated interferon-alpha2a for the treatment of lamivudine-resistant hepatitis B virus infection in HIV-infected patients.

Ingiliz, Patrick; Valantin, Marc-Antoine; Thibault, Vincent; Duvivier, Claudine; Dominguez, Stephanie; Katlama, Christine; Poynard, Thierry; Benhamou, Yves.

Antivir Ther ; 13(7): 895-900, 2008.

Artigo em Inglês | MEDLINE | ID: mdl-19043923

10.

Viral hepatitis C.

Poynard, Thierry; Yuen, Man-Fung; Ratziu, Vlad; Lai, Ching Lung.

Lancet ; 362(9401): 2095-100, 2003 Dec 20.

Artigo em Inglês | MEDLINE | ID: mdl-14697814

11.

Similarities and differences between REPEAT and EPIC3.

Poynard, Thierry; Shiff, Eugene.

Ann Intern Med ; 151(10): 754; author reply 754-5, 2009 Nov 17.

Artigo em Inglês | MEDLINE | ID: mdl-19920277

12.

Pegylated interferon alpha 2b and ribavirin in HIV/hepatitis C virus-co-infected non-responders and relapsers to IFN-based therapy.

Myers, Robert P; Benhamou, Yves; Bochet, Marie; Thibault, Vincent; Mehri, Delphine; Poynard, Thierry.

AIDS ; 18(1): 75-9, 2004 Jan 02.

Artigo em Inglês | MEDLINE | ID: mdl-15090832

13.

Treatment of cirrhotic patients in the pegylated interferon era.

Poynard, Thierry.

Dig Liver Dis ; 36 Suppl 3: S344-8, 2004 Nov.

Artigo em Inglês | MEDLINE | ID: mdl-15645665

14.

Anti-hepatitis C virus antibody detection in oral fluid: influence of human immunodeficiency virus co-infection.

Visseaux, Benoit; Larrouy, Lucile; Calin, Ruxandra; Katlama, Christine; Poynard, Thierry; Ratziu, Vlad; Thibault, Vincent.

J Clin Virol ; 58(2): 385-90, 2013 Oct.

Artigo em Inglês | MEDLINE | ID: mdl-23953940

15.

Biochemical surrogate markers of liver fibrosis and activity in a randomized trial of peginterferon alfa-2b and ribavirin.

Poynard, Thierry; McHutchison, John; Manns, Michael; Myers, Rob P; Albrecht, Janice.

Hepatology ; 38(2): 481-92, 2003 Aug.

Artigo em Inglês | MEDLINE | ID: mdl-12883493

16.

Effect of treatment with peginterferon or interferon alfa-2b and ribavirin on steatosis in patients infected with hepatitis C.

Poynard, Thierry; Ratziu, Vlad; McHutchison, John; Manns, Michael; Goodman, Zachary; Zeuzem, Stefan; Younossi, Zobair; Albrecht, Janice.

Hepatology ; 38(1): 75-85, 2003 Jul.

Artigo em Inglês | MEDLINE | ID: mdl-12829989

17.

Impact of pegylated interferon alfa-2b and ribavirin on liver fibrosis in patients with chronic hepatitis C.

Poynard, Thierry; McHutchison, John; Manns, Michael; Trepo, Christian; Lindsay, Karen; Goodman, Zachary; Ling, Mei-Hsiu; Albrecht, Janice.

Gastroenterology ; 122(5): 1303-13, 2002 May.

Artigo em Inglês | MEDLINE | ID: mdl-11984517

18.

Adherence to combination therapy enhances sustained response in genotype-1-infected patients with chronic hepatitis C.

McHutchison, John G; Manns, Michael; Patel, Keyur; Poynard, Thierry; Lindsay, Karen L; Trepo, Christian; Dienstag, Jules; Lee, William M; Mak, Carmen; Garaud, Jean-Jacques; Albrecht, Janice K.

Gastroenterology ; 123(4): 1061-9, 2002 Oct.

Artigo em Inglês | MEDLINE | ID: mdl-12360468

BVS Odontologia

Informação e Conhecimento para a Saúde

Configurar filtros

Sua seleção (0)

Formato de exportação:

Exportar: